Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs59626664 | chr12:56636975 | C/G | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs59811639 | chr12:56695954 | C/T | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs59822547 | chr12:56644886 | A/G | 1.09E-7 | 177 | 25.17 | 27.33 | 0.8 | KM Plot |
PCPG | rs59863111 | chr21:34606972 | GGGTTTGTCT/G | 0.000294 | 172 | 21.9 | 31.97 | 25.17 | KM Plot |
PCPG | rs59889656 | chr3:39168309 | T/A | 7.83E-7 | 178 | 25.87 | 20.47 | 24.72 | KM Plot |
PCPG | rs59917308 | chr12:56658708 | C/T | 1.24E-7 | 176 | 25.08 | 27.33 | 0.8 | KM Plot |
PCPG | rs59959484 | chr1:56345876 | C/T | 2.43E-5 | 170 | 25.87 | 26.12 | 13.27 | KM Plot |
PCPG | rs5997038 | chr22:21279805 | A/G | 7.74E-5 | 177 | 12.57 | 31.68 | 25.2 | KM Plot |
PCPG | rs5997064 | chr22:21299577 | G/A | 7.74E-5 | 177 | 12.57 | 31.68 | 25.2 | KM Plot |
PCPG | rs60012050 | chr8:6734378 | AC/A | 1.34E-6 | 172 | 10.73 | 19 | 27.3 | KM Plot |
PCPG | rs6004914 | chr22:21274587 | A/G | 2.42E-5 | 176 | 12.93 | 31.9 | 25.4 | KM Plot |
PCPG | rs6004917 | chr22:21275859 | A/G | 4.21E-6 | 178 | 25.2 | 31.68 | 12.93 | KM Plot |
PCPG | rs6004944 | chr22:21282756 | C/A | 2.05E-5 | 178 | 12.93 | 31.68 | 25.2 | KM Plot |
PCPG | rs6005013 | chr22:21301992 | G/A | 8.42E-5 | 176 | 12.93 | 31.47 | 25 | KM Plot |
PCPG | rs60053485 | chr1:244157197 | T/A | 3.77E-5 | 171 | 27.95 | 20.13 | 9.48 | KM Plot |